滚动资讯
FierceBiotechChutes & Ladders—Eric Topol boards Flagship as advisorFierceBiotechBehind the curtain: What Xaira is building after its $1B fundraiseFierceBiotechIntuitive recalls surgical stapler reloads following patient deathAgilent安捷伦在美国病理学家协会2026年大会上推出扩展的PD-L1检测与数字病理工作流程 - 临床实验室产品BioPharma DiveRoche stops work on experimental SMA drugEndpoints NewsSarepta to ask FDA for full approval of exon skipping drugs; Rhythm's label expansion in rare form of obesityEndpoints NewsChina-rooted AI biotech Earendil Labs raises $787M ahead of possible IPOEndpoints NewsUK’s NICE revisits Lilly, Eisai Alzheimer's drugs under new pricing thresholdBioPharma DiveNovartis pays $2B to land a startup’s breast cancer drugAgilent安捷伦在韩国实验室2026展会上展示自动化实验室的未来 - marketscreener.comPharmaVoiceGilead could potentially end HIV. But will it be able to?BioWorldTreeline Biosciences reports TEAD degraders
Agilent 2026年1月22日

安捷伦科技（NYSE:A）本周下跌4.2%，年度回报率与盈利增长更趋一致——雅虎财经

安捷伦科技（NYSE:A）本周下跌4.2%，年度回报率与盈利增长更趋一致——雅虎财经

原文
暂时没有全文，请查看原始来源。

目录

59 全部